Exon 5-deleted Oestrogen Receptor in Breast Cancer
Author Information
Author(s): AJ Desai, YA Luqmani, JE Walters, RC Coope, B Dagg, JJ Gomm, PE Pace, CN Rees, V Thirunavukkarasu, S Shousha, NP Groome, R Coombes, S All
Primary Institution: Charing Cross and Westminster Medical School
Hypothesis
Does the presence of the exon 5-deleted oestrogen receptor (HEA5) mRNA variant in breast cancer correlate with clinical outcomes?
Conclusion
The presence of HEA5 mRNA in breast cancer is associated with better disease-free survival, but it is not an independent prognostic factor.
Supporting Evidence
- HEA5 mRNA was present in 32% of carcinomas compared to 13% in non-malignant tissues.
- Presence of HEA5 was associated with better disease-free survival.
- HEA5 was found in 44% of ER+/PR+ cancers.
- Statistical analysis showed significant correlations with ER and PR status.
Takeaway
This study looked at a special type of oestrogen receptor in breast cancer and found that having it might mean a better chance of staying cancer-free.
Methodology
The study used reverse transcriptase polymerase chain reaction (RT-PCR) to examine HEA5 mRNA in breast biopsies and correlated its presence with clinical features.
Limitations
The study did not find HEA5 as an independent prognostic factor despite its association with better survival.
Participant Demographics
Patients undergoing surgery at St George's Hospital or the Royal Marsden Hospital in London between 1976 and 1990.
Statistical Information
P-Value
p=0.05
Confidence Interval
95% CI
Statistical Significance
p=0.05
Want to read the original?
Access the complete publication on the publisher's website